Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2024-05-22 00:00:00 ET · period of report 2024-05-20 · accession 0000950170-24-063482 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-22 | 2024-05-20 | IRWD | Davis Andrew | SVP, Chief Business Off | S - Sale | $6.45 | -22.7K | 288.0K | -7% | -$146.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-05-20 | S | D | 22,725 | $6.45 | 288,031 | D | — | — |